Trial Profile
Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 Polymorphism
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ramosetron (Primary) ; Palonosetron
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 25 Oct 2017 Status changed from recruiting to completed.
- 02 Jul 2015 New trial record